ATP-LONG 10 mg or 20 mg, Adenine Nucleotide 6.3 g/12.6 g.
ATP-LONG is a unique new class medicine containing adenosine-5’- triphosphate (ATP), histidine amino acid, magnesium and potassium. Its original molecule structure demonstrates a pharmacological effect, which none of its chemical components has. ATP-LONG’s effect is anti-ischemial, membrane stabilizing and antiarrhythmic. ATP-LONG normalizes metabolism, improves the myocardial anti-oxidation protection system, and reduces accumulation of hydrolysis products in membranes and the peroxidation of phospholipids. ATP-LONG improves central and peripheral hemodynamics and coronary blood circulation, and increases myocardial contractile ability, the function of the left ventricle and cardiac output, resulting in better physical efficiency. ATP-LONG reduces the frequency of stenocardia, normalizes potassium and magnesium tissue concentrations and reduces uric acid concentrations.
- indicated for the treatment of cardiac ischemia, unstable stenocardia;
- post-infarction and myocardial cardiosclerosis;
- cardiac insufficiency;
- vegetovascular dystonia;
- myocardial dystrophy;
- infectious allergic myocarditis;
- chronic fatigue syndrome.
Dosage and pharmaceutical form:
tablets 10 mg or 20 mg, 10 tablets in blister, 4 blisters in package.